Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein PET100 homolog, mitochondrial (PET100) is a highly conserved mitochondrial chaperone essential for the assembly and stabilization of cytochrome c oxidase (complex IV) of the mitochondrial respiratory chain[1][2][3][5][7]. Localized to the inner mitochondrial membrane and exposed to the intermembrane space, PET100 acts as an assembly factor that coordinates integration of core subunits and ancillary proteins, working together with PET117 and MR-1S to ensure effective complex IV formation. Loss-of-function mutations in PET100 disrupt assembly of complex IV, causing severe mitochondrial disorders such as Leigh syndrome and fatal infantile lactic acidosis, with features of neurodegeneration and impaired energy production[1][5][7][9]. Currently, PET100 is not considered a direct therapeutic target but is important as a disease gene whose mutation results in profound deficiency of mitochondrial electron transport and cellular respiration.
PET100 is not known to be a direct target of drug interventions—it is a chaperone required for cytochrome c oxidase maturation[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein PET100 homolog, mitochondrial (PET100).